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The majority of hepatitis B virus (HBV) transcripts are not normally spliced during the viral life cycle, but several splice
donor and acceptor sites are conserved on HBV transcripts. In particular, the genome region between nt 450 and 500 of the
HBV genome appears to be rich in such sequences. In this study we deleted a short 30-nt sequence between a conserved
splice donor site at HBV genome position 462 and a splice acceptor site at position 491, thus deleting the surface/polymerase
open reading frames by 10 amino acid residues. At the transcriptional level, this deletion led to .99% reduction of the 2.1-kb
class of subgenomic transcripts in transfected cells. Nuclear run-on experiments revealed that the transcription rate of the
deleted 2.1-kb transcript is unchanged when compared with the wildtype, suggesting a posttranscriptional mechanism for the
downregulation of the deleted transcript. In addition, experiments with a replication-competent HBV mutant containing the
30-nt deletion showed that the corresponding 10-amino-acid sequence within the reverse transcriptase domain of the
polymerase protein appeared to be nonessential. © 1999 Academic Press
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Exposure to hepatitis B virus (HBV) often leads to
ersistent viral infection of the liver, cirrhosis, and he-
atocellular carcinoma. HBV is a DNA virus that repli-
ates asymmetrically through reverse transcription of an
NA intermediate. HBV has a 3.2-kb partially double-
tranded DNA genome from which four major classes of
ranscripts are synthesized. The 3.5-kb pregenomic RNA
ot only serves as template for reverse transcription, but
lso contains coding regions for the nucleocapsid pro-
ein and the reverse transcriptase. A subclass of this
ranscript with a slightly longer 59 end codes for the
recore protein, which, after processing, is secreted as
BV e antigen (HBeAg). The 2.4-kb RNA encompasses
he preS1 open reading frame (ORF) that encodes the
arge surface (L) protein. The 2.1-kb RNA contains the
reS2 and S ORFs that encode the middle (M) and small
s) surface proteins, respectively. The smallest transcript
approximately 0.9 kb) codes for the X protein. A common
olyadenylation site is believed to be utilized by all tran-
cripts.
Mutations and deletions in the HBV genome have
requently been detected during persistent viral infection.
n this regard, studies have emphasized the potential
1 Present address: Department of Internal Medicine, University of
reiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany.
2 To whom correspondence and reprint requests should be ad-
ressed at Molecular Hepatology Laboratory, MGH Cancer Center, 149
3th Street, Charlestown, MA 02129. Fax: (617) 726-5609. E-mail:hands@helix.mgh.harvard.edu.
245athogenic role of mutations in the precore and core
romoter regions, the precore and core ORFs, and the
re-S region (Gerken et al., 1991; Melegari et al., 1997;
kamoto et al., 1987; Tran et al., 1991). For example, HBV
ariants exist in certain patients that carry deletions in
he promoter region for the M and s proteins and there-
ore are unable to direct the synthesis of transcripts
oding for these proteins. This phenomenon may influ-
nce the pathogenesis of HBV infection.
Little is known about determinants governing the in-
racellular stability and translocation of HBV transcripts.
espite numerous well-conserved regions in the HBV
enome that represent consensus sequences for splice
onor and acceptor sites, spliced transcripts of HBV
ave been detected only at low levels (Chen et al., 1989;
osmorduc et al., 1995; Su et al., 1989a; 1989b; Suzuki et
l., 1989, 1990; Terre et al., 1991; Wu et al., 1991), and
either a function for splicing in viral replication nor a
ole for splice transcripts and associated novel proteins
n the pathogenesis of chronic hepatitis has been firmly
stablished. It appears that the majority of HBV tran-
cripts are not spliced during the viral life cycle, which
aises the question why several splice donor and accep-
or sites are conserved on HBV transcripts. In particular,
he genome region between nt 450 and 500 of the HBV
enome appears to be rich in such sequences. A splice
onor site at position 462 has been shown to be effec-
ively utilized in the context of chimeric and endogenous
ranscripts (Cattaneo et al., 1984; Graef et al., 1994; Si-
onsen and Levinson, 1983; Wang et al., 1992), and a
plice acceptor site 30 nt downstream, at position 491,
as been found to be involved in splicing of large introns
0042-6822/99 $30.00
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246 ZU PUTLITZ, TONG, AND WANDSrom the 3.5-kb class of transcripts (Rosmorduc et al.,
995; Su et al., 1989a; Suzuki et al., 1990; Terre et al.,
991; Wu et al., 1991).
The present study demonstrates that the short 30-nt
equence between the splice donor site at HBV genome
osition 462 and the splice acceptor site at HBV genome
osition 491 appears to be essential for the posttran-
criptional maintenance of the 2.1-kb class of sub-
enomic transcripts. Deletion of this sequence also had
odulatory effects on the levels of 3.5- and 2.4-kb tran-
cripts. However, experiments with a HBV mutant con-
aining the 30-nt deletion show that the corresponding
0-amino-acid sequence within the reverse transcriptase
RT) domain of the polymerase protein appears to be
onessential for viral DNA synthesis.
RESULTS
plicing of HBV at genome position 462
For the study of certain regions of the HBV genome for
se as antisense and sense RNAs, a subgenomic frag-
ent of the HBV genome (HBV 288-919; G of the EcoRI
ite is position 1) was inserted in the antisense and, for
FIG. 1. Splicing of a HBV-b globin chimeric transcript at genome posi
nd 288-919 sense (bottom). After splicing of the 573-nt-long intron 2
without the poly(A) tail) consisting of a 75-nt CMV-encoded leader seq
rom the HBV genome) orientation, and 373 nt of rabbit b-globin gene s
enome position 462 was unexpectedly found to be utilized. The splic
74 nt of HBV DNA inserted in the sense orientation, and 373 nt of rabbi
lot analysis of total cellular RNA from transfected HuH-7 cells to dete
days after transfection. Note the length difference between the two
espectively. Positions of RNA length markers (nt) are indicated on theontrol purposes, in the sense orientation (relative to the srientation in the HBV genome) into the eukaryotic ex-
ression vector pC-GR N-795 (Rusconi et al., 1990) under
ontrol of the cytomegalovirus immediate-early (CMV-IE)
romoter. In the vector pC-GR N-795, sequences from
he rabbit b-globin-like gene cluster, including the 573-nt
ntron 2, are located 39 to its unique BamHI cloning site
o facilitate nucleocytoplasmic export of transcribed and
ubsequently spliced RNAs, thereby enhancing the num-
er of transcripts available for translation (see Fig. 1A). In
rder to analyze expression of the antisense and sense
NAs, the constructs 288-919 antisense and 288-919
ense were transiently transfected in HuH-7 hepatoma
ells. Analysis of total cellular RNA on Northern blot and
ybridization with a HBV-specific probe revealed that the
BV 288-919 antisense transcript had the expected size
f approximately 1300 nt including a poly(A) stretch of an
stimated length of 200 to 300 nt (Fig. 1B, lane 1). How-
ver, the HBV 288-919 sense transcript appeared to be
00 nt in length (lane 2), much shorter than the expected
ize of 1300 nt.
This finding was unexpected because several other
ntisense/sense RNA pairs studied in similar experi-
ents were of the same apparent length (data not
. (A) Diagram of the organization of transcripts 288-919 antisense (top)
liced transcript 288-919 antisense has a predicted length of 1083 nt
635 nt of HBV DNA inserted in antisense (with respect to transcription
es. In the transcript 288-919 sense, a cryptic splice donor site at HBV
script therefore consists of the 75-nt CMV-encoded leader sequence,
in gene sequence totaling 608 nt (without the poly(A) tail). (B) Northern
ed transcripts 288-919 antisense (lane 1) and 288-919 sense (lane 2)
ripts. 28 S and 18 S, relative position of human 28S and 18S rRNAs,tion 462
, the sp
uence,
equenc
ed tran
t b-glob
ct splic
transchown). It was hypothesized that the smaller size of the
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247HBV TRANSCRIPT LEVEL DETERMINANTBV 288-919 sense transcript was due to an aberrant
plicing event involving, on the 59 end, certain se-
uences within the HBV portion of the transcript and on
he 39 end portions of the rabbit b-globin intron 2. As will
e described elsewhere in more detail (zu Putlitz et al.,
anuscript in preparation), this possibility was investi-
ated by performing RT-PCR from total cellular RNA of
BV 288-919 antisense- and HBV 288-919 sense-trans-
ected HuH-7 cells. Sequence analysis of subcloned PCR
ragments revealed that the smaller HBV 288-919 sense
NA was indeed spliced at a putative splice donor (59-)
ite within the HBV genome, located at position 462. It
as noteworthy that this splice donor site, which is
ighly conserved among all genotypes of HBV (see Fig.
), was located exactly 30 nt upstream of an also highly
onserved and well-characterized splice acceptor (39-)
ite (at position 491) previously described in the context
f generation of spliced transcripts of HBV (Rosmorduc
t al., 1995; Su et al., 1989a; Suzuki et al., 1990; Wu et al.,
FIG. 2. (A) Multiple sequence alignment of 24 HBV sequences availa
he EcoRI site is position 1). The alignment was performed using the Cl
heir GenBank accession number (source). The listed subtypes and gen
nd several undefined subtypes of HBsAg sequences are labeled as
otally conserved regions around HBV positions 459 to 470 and 490 to
coRI site is position 1) and corresponding surface and polymerase OR
n-frame deletions (boxed) in both reading frames. Pol455–463, positio
olymerase ORF (Rehermann et al., 1995).991). Thus, splicing of a heterologous transcript was Cbserved at the splice donor site position 462 that was
ocated in close proximity to the splice acceptor site at
osition 491. Both sites lie within a genome region of
BV that encodes the surface antigens and the reverse
ranscriptase domain of viral polymerase.
30-nt deletion in the reverse transcriptase region of
he polymerase gene does not affect viral DNA
ynthesis, but abolishes surface antigen production
The observed high degree of conservation between
enotypes with respect to splice consensus sequences
as noteworthy because most HBV transcripts are not
pliced. We hypothesized that the clustered splice con-
ensus sequences played some unknown important
unctional role(s) in the life cycle of HBV. This possibility
as first investigated by generation of a 30-nt deletion
etween the splice donor site at position 462 and the
plice acceptor site at position 491. For this purpose, a
the GenBank database in the region of nt positions 432 to 521 (G of
Multiple Sequence Alignment program. All sequences are denoted by
are from the original references. HBsAg mutants are denoted as “mut”
e sequence from HBV nt 462 to 491 is depicted in lowercase letters.
re boxed. (B) Diagram of the HBV genome region nt 446 to 508 (G of
letion of 30 nt between genome positions 462 and 491 leads to 10-aa
previously identified HLA-A2-restricted CTL epitope located in theble from
ustalW
otypes
“nd.” Th
492 a
Fs. De
n of aMV-IE promoter-driven expression construct for HBV
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248 ZU PUTLITZ, TONG, AND WANDSregenomic RNA incorporating the described 30-nt de-
etion, termed pTC-HBV-D30, was generated. The 30-nt
eletion in pTC-HBV-D30 was predicted to lead to 10-aa
n-frame deletions in all three surface proteins and the
everse transcriptase domain of viral polymerase (see
ig. 2B). The parental construct, pTC-HBV, contains en-
ogenous promoter regions for all subgenomic HBV tran-
cripts and therefore gives rise to virus particles when
ransfected into hepatoma cells. pTC-HBV-D30 and its
ildtype control, pTC-HBV, were transiently transfected
nto HuH-7 hepatoma cells. pTC-HBV-FS645, a CMV-IE
romoter-driven frameshift mutant of HBV that was en-
apsidation- and replication- incompetent (unpublished
ata), was used as negative control in these experi-
ents. First, encapsidation of pregenomic transcripts
nto nucleocapsids was investigated. For this purpose,
ransfected cells were lysed and nucleocapsids were
recipitated with PEG (Tong et al., 1992) and digested
ith proteinase K. Using this procedure, only the portion
f pregenomic RNA that is encapsidated into nucleocap-
ids (and is therefore available for replication) will be
etected on Northern blot (Fig. 3A), whereas all unpack-
FIG. 3. Encapsidation and replication of the D30 deletion mutant. (A
rom PEG-precipitated nucleocapsids (Tong et al., 1992) after transfectio
TC-HBV-FS645 (frameshift mutant at HBV genome position 645). Preg
rom the frameshift mutant HBV-FS645 (lane 2) are encapsidated into n
). 28 S and 18 S, relative position of human 28S and 18S rRNAs. (B) So
fter transfection of DNA constructs pTC-HBV, pTC-HBV-D30, and pTC-
r adw-R9-D30. WT-HBV (lanes 2 and 6) and the D30 mutant (lane
elaxed-circular (RC), double-stranded linear (DS), and single-stranded
). Lane 1, marker for the position of HBV DS DNA. NC, negative control
rom cells transfected with CMV-promoter bearing constructs were anal
ransfected with recircularized monomers were analyzed for HBsAg an
egative).ged nucleic acids are eliminated by prior DNase and DNase digestion. As demonstrated in Fig. 3A, lane 1, a
trong signal corresponding to pregenomic RNA (length
.5 kb) was observed when WT-HBV DNA was trans-
ected. The same result was obtained in the case of
regenomic RNA transcribed from the plasmid pTC-HBV-
30 (lane 3), while no signal representative of encapsi-
ated pregenomic RNA was detectable in the HBV
rameshift mutant HBV-FS645. These data suggested
hat the deleted pregenomic RNA could be efficiently
ncapsidated into nucleocapsids.
Next, viral DNA synthesis of WT HBV and the D30
utant was explored. Transient transfections with plas-
ids pTC-HBV, pTC-HBV-D30, and pTC-HBV-FS645 were
erformed as described above. Four days after transfec-
ion, nucleocapsid-associated HBV DNA products were
nalyzed on Southern blot with a HBV-specific probe. As
emonstrated in Fig. 3B, lane 4, the D30 mutant exhibited
pattern of hybridization similar to the WT pattern (lane
). All HBV products indicative of virus replication,
amely, relaxed-circular (RC), double-stranded linear
DS), and single-stranded (SS) DNA, were observed. This
esult suggested that the D30 mutant was competent for
ern blot detection of encapsidated, pregenomic RNA (3.5 kb) isolated
A constructs pTC-HBV (WT), pTC-HBV-D30 (D30 deletion mutant), and
transcripts from WT HBV (lane 1) and the D30 mutant (lane 3) but not
psids. NC, negative control (mock-transfected HuH-7 HCC cells; lane
blot analysis of nucleocapsid-associated replication products of HBV
645 or recircularized HBV monomers derived from constructs adw-R9
d 7) show HBV-specific signals indicative of virus DNA synthesis:
A. No DNA synthesis is detectable with the mutant HBV-FS645 (lane
transfected HuH-7 HCC cells; lane 5). In addition, culture supernatants
r the presence of HBsAg and HBcAG, whereas supernatants from cells
Ag. Qualitative results are indicated below each lane (1, positive; 2) North
n of DN
enomic
ucleoca
uthern
HBV-FS
s 4 an
(SS) DN
(mock-
yzed fo
d HBeNA synthesis in transfected cells, despite a 10-aa de-
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249HBV TRANSCRIPT LEVEL DETERMINANTetion in the reverse transcriptase domain of the viral
olymerase. As expected, no replication was detected
ith the mutant HBV-FS645 (lane 3). Cell culture super-
atants from transfected cells were assayed by radioim-
unoassay for the presence of the viral surface antigen
HBsAg) and the core antigen (HBcAg) (Fig. 3B). HBcAG
as detectable in supernatants from D30-, WT-, and
S645-transfected cells. However, quantitation of HBcAg
evealed 80% reduction of HBcAg levels in the case of
BV-D30 and 50% reduction in HBV-FS645 (data not
hown). Of note, no HBsAg was detectable in cell culture
upernatants from HBV-D30-transfected cells, either by
onoclonal radioimmunoassay or by immunodetection
f surface antigens on Western blot with a polyclonal
nti-HBs antiserum (data not shown). Transient transfec-
ions with recircularized HBV monomers were performed
o assess the impact of the 30-nt deletion in the absence
f any heterologous regulatory elements. For this pur-
ose, the construct adw-R9-D30 was generated. HBV
onomers were generated from this construct and the
arental plasmid, adw-R9. Wildtype HBV and deleted
onomers were religated and transfected into HuH-7
CC cells. As demonstrated in Fig. 3B, lane 7, the D30
utant exhibited a pattern of hybridization similar to the
T pattern (lane 6), confirming the results obtained with
he CMV promoter bearing constructs. Cell culture su-
ernatants from transfected cells were assayed by ra-
ioimmunoassay for the presence of HBsAg and HBeAg.
BeAg was detectable in supernatants from both adw-
9- and adw-R9-D30-transfected cells. No HBsAg was
etectable in supernatants from adw-R9-D30-transfected
ells. Taken together, these results demonstrated that
he deletion of 10 aa in the reverse transcriptase domain
f polymerase does not affect the competence of the
iral enzyme for DNA synthesis but that the deletion of
he corresponding 10 aa in the surface antigen ORF
eads to undetectable HBsAg levels.
ranscript analysis
The possibility that transcription or translation of sur-
ace proteins was altered in the D30 mutant was inves-
igated next. In one set of experiments, cells were trans-
ected with the CMV promoter bearing constructs pTC-
BV (Fig. 4, lane 1), pTC-HBV-FS645 (lane 2), or pTC-
BV-D30 (lane 3). In a second set of experiments, cells
ere transfected with recircularized HBV monomers de-
ived from the construct adw-R9 (Fig. 4, lane 5) or recir-
ularized, deleted HBV monomers derived from the con-
truct adw-R9-D30 (lane 6). Lysates from transfected
ells were analyzed for the synthesis of HBV transcripts
y Northern blot with a HBV-specific probe (Fig. 4, top).
or loading control purposes the same membranes were
tripped and reprobed with a probe specific for the
cidic ribosomal phosphoprotein PO (Krowczynska et al.,
989) (Fig. 4, bottom). The transfection efficiencies as setermined by human growth hormone (hGH) assay
ere similar in all individual experiments. For WT HBV,
hree major classes of transcripts, designated 3.5 kb
pregenomic RNA), 2.4 kb (the transcript encoding the L
rotein), and 2.1 kb (the transcript encoding the M and s
roteins) were detectable (Fig. 4, lane 1). Because tran-
cription of the 3.5-kb class of transcripts was driven by
he heterologous CMV-IE promoter, the relative amount
f this class of transcripts was elevated compared to
ranscription driven by the endogenous viral promoter. A
omewhat lower level of all three transcripts was ob-
erved in the case of the nonreplicating mutant (lane 2).
t is currently unclear why HBV-FS645 gives rise to re-
uced levels of HBV transcripts in transfected cells. In
he case of the D30 mutant, levels of the 3.5- and 2.4-kb
lasses of transcripts carrying the 30-nt deletion were
arkedly reduced (lane 3). Strikingly, the class of 2.1-kb
ranscripts was absent. Densitometric analysis revealed
hat the levels of the deleted 3.5- and 2.4-kb classes of
ranscripts were reduced by 80% (lane 3) when com-
ared with the WT levels (data not shown). Similar re-
FIG. 4. Reduction of HBV transcripts by the D30 mutant. (Top left)
orthern blot analysis of total cellular RNA isolated 3 days after trans-
ection of DNA constructs pTC-HBV (WT), pTC-HBV-D30 (D30 deletion
utant) and pTC-HBV-FS645 (frameshift mutant at HBV genome posi-
ion 645) in HuH-7 HCC cells and detection with a HBV-specific probe.
ransfection efficiencies were comparable in all cases. Transcripts
orresponding to pregenomic RNA (3.5 kb), L protein-encoding RNA
2.4 kb), and M and s protein-encoding RNA (2.1 kb) are visible in the
ase of WT-HBV (lane 1) and HBV-FS645 (lane 2). Note that the 2.1-kb
lass of transcripts is not detectable and 3.5- and 2.4-kb transcript
evels are reduced in the case of HBV-D30 (lane 3). NC, negative
ontrol (mock-transfected HuH-7 HCC cells; lane 4). (Top right) North-
rn blot analysis of total cellular RNA isolated 3 days after transfection
f recircularized HBV monomers derived from adw-R9 (WT, lane 5) or
dw-R9-D30 (D30 deletion mutant, lane 6) in HuH-7 HCC cells. The
.1-kb class of transcripts is not detectable in the case of the D30
eletion mutant, whereas the 3.5- and 2.4-kb transcript levels are
imilar to that of WT. (Bottom) Rehybridization of the same membranes
ith a labeled probe specific for the acidic ribosomal phophoprotein
O (ARPP PO) (Krowczynska et al., 1989) (a kind gift from Robert
urford) for loading control purposes. 28 S and 18 S, relative position
f human 28S and 18S rRNAs.ults were obtained when the constructs described
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250 ZU PUTLITZ, TONG, AND WANDSbove were transfected into HEK 293 human embryo
idney cells (Graham et al., 1977) (data not shown). When
ecircularized WT or deleted HBV monomers were trans-
ected, there was no reduction of the deleted 3.5- and
.4-kb classes of transcripts (Fig. 4, lane 6) compared to
he WT (lane 5). However, the 2.1-kb class of transcripts
as undetectable in the case of the deleted monomer,
onfirming the results of transfection experiments with
he CMV promoter bearing constructs. Taken together,
hese data suggested that HBsAg is absent from super-
atants of cells transfected with the HBV-D30 mutant
ecause of the lack of the corresponding class of tran-
cripts.
etection of deleted 2.1-kb transcripts
The absence of the 2.1-kb class of transcripts carrying
he 30-nt deletion was further evaluated by transfection
xperiments using a construct that encoded the 2.1-kb
lass and 0.9-kb class of transcripts only. The construct
BV PreS/X (McLachlan et al., 1987), which contained
BV nucleotides 2837–1989 (a kind gift from Alan
cLachlan), included HBV sequences corresponding to
he HBV S promoter, the complete S ORF, and the HBV
oly(A) recognition sequence but lacked the preS pro-
oter. A derivative of this construct carrying the 30-nt
eletion from position 462 to 491, HBV PreS/X-D30, was
enerated. HuH-7 cells were transfected with the WT
lasmid, HBV PreS/X, or the mutation-bearing plasmid
BV PreS/X-D30, and lysates from transfected cells 3
ays posttransfection were analyzed by Northern blot
ith a HBV-specific probe. As illustrated in Fig. 5A, a
ignal corresponding to the 2.1-kb class of HBV tran-
cripts was detected after transfection of the WT plasmid
lane 1). In constrast, no signal was obtained after trans-
ection of the mutation-carrying plasmid (lane 2). Similar
esults were obtained when the constructs described
bove were transfected into HEK 293 human embryo
idney cells (data not shown).
To test the possibility that Northern blot analysis was
ot sensitive enough to detect trace amounts of the
.1-kb class of transcripts synthesized by the D30 mutant,
sensitive RT-PCR assay was developed. HBV primers
hat were able to specifically amplify the 2.1-kb class of
ranscripts in this experimental setting were utilized, and
T-PCR was performed from the same lysates previously
nalyzed on Northern blot (see Fig. 5A). To avoid coam-
lification of the 0.9-kb class of HBV transcripts that were
lso encoded by the construct HBV PreS/X, one PCR
rimer (19661 (Kock et al., 1996); see Materials and
ethods) was derived from a HBV genome region that
as positioned 59 to the putative transcription initiation
ite for this class of transcripts, whereas the second PCR
rimer (2830-) was derived from a region shared by both
lasses of transcripts. PCR products were visualized by
garose gel electrophoresis (Fig. 5B, top) as well as by fouthern blot using a HBV-specific probe (Fig. 5B, bot-
om). As demonstrated in Fig. 5B, lane 1, a HBV-specific
CR product corresponding to the 2.1-kb class of tran-
cripts was observed in lysates of cells transfected with
he WT construct, HBV PreS/X. Of note, a weaker HBV-
pecific signal was also detected in lysates of cells
ransfected with the construct carrying the 30-nt deletion,
BV PreS/X-D30 (lane 3); control reactions carried out in
he absence of reverse transcriptase were negative in
oth cases (lanes 2 and 4, respectively). These results
uggest that introduction of the 30-nt deletion did not
ompletely abolish the production of the 2.1-kb class of
ranscripts, i.e., that 2.1-kb transcripts carrying the 30 nt
eletion were indeed produced in transfected cells, al-
eit at very low levels. However, it is important to note
hat the PCR assay used here cannot discriminate be-
ween a nuclear and a cytoplasmic localization of the
eleted 2.1-kb transcript. It is therefore possible that the
CR product we detected corresponds to deleted 2.1-kb
ranscripts that were located in the nucleus of trans-
FIG. 5. Characterization of 2.1-kb subgenomic transcripts produced
y the D30 mutant. (A) (Top) Northern blot analysis of total cellular RNA
solated 3 days after transfection of DNA constructs HBV PreS/X (WT)
nd HBV PreS/X-D30 (D30 deletion mutant) in HuH-7 HCC cells and
etection with a HBV-specific probe. A signal corresponding to the
ubgenomic 2.1-kb class of transcripts is observed in the case of the
T (lane 1), but not when the 30-nt deletion is present (lane 2). NC,
NA from mock-transfected HuH-7 cells. (Bottom) Visualization of 28S
RNA for loading control purposes. 28 S and 18 S, relative position of
uman 28S and 18S rRNAs. (B) RT-PCR analysis of the same total
ellular RNA preparation analyzed in (A). Agarose gel fractionation (top)
nd Southern blot detection with a HBV-specific probe (bottom) of PCR
roducts obtained after reverse transcription and amplification with
rimers 19661 and 28302 (Kock et al., 1996). A specific amplification
roduct (890 nt) corresponding to the presence of the 2.1-kb class of
ranscripts is detected in both the WT (lane 1) and the D30 mutant (lane
), although the signal is much weaker in the case of the D30 mutant.
ontrol reactions performed in the absence of reverse transcriptase
re negative in both cases (lanes 2 and 4, respectively).ected cells.
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251HBV TRANSCRIPT LEVEL DETERMINANTuclear run-on assay
To compare the transcription rates of transcripts de-
ived from HBV PreS/X and HBV PreS/X-D30, a nuclear
un-on assay was performed using nuclei isolated from
ransiently transfected cells. Labeled transcripts synthe-
ized by isolated nuclei were hybridized to plasmid DNA
hat had been dot blotted on nylon membranes. Labeled
ranscripts were incubated with PreS/X DNA, with hGH
NA for assessment of variations in transfection efficien-
ies, with ARPP-PO DNA as endogenous control, and
ith pUC13 DNA as negative control. Signal intensities
ere quantified by densitometry using a phosphoimager
ystem. As demonstrated in Fig. 6, strong signals corre-
ponding to hGH and PreS/X transcripts were observed
n the cases of the HBV PreS/X and the HBV PreS/X-D30
ranscripts. The calculation of signal ratios (PreS/X to
GH) revealed comparable values in both instances,
ndicating that relative signal intensities were similar. A
tatistical analysis of signal ratios revealed no significant
ifference between the relative strengths of RNA signals
btained with HBV PreS/X and HBV PreS/X-D30 (data not
hown). These data suggest that the transcription rate of
he deleted HBV 2.1-kb transcript is similar to its wildtype
ounterpart and provide indirect evidence for a posttran-
criptional mechanism leading to reduced levels of the
ranscript with the 30-nt deletion.
DISCUSSION
The present study describes the occurrence of an
FIG. 6. Nuclear run-on assay. Transcription rates of mRNAs from
uH-7 HCC cells transfected with the HBV PreS/X and HBV PreS/X-D30
onstructs. Labeled transcripts were hybridized to corresponding plas-
id DNA that had been dot blotted on nylon membranes. Labeled
ranscripts were also incubated with hGH DNA for assessment of
ariations in transfection efficiencies, with ARPP-PO DNA as endoge-
ous control and with pUC13 DNA as negative control. Signal intensi-
ies were quantified by densitometry using a phosphoimager system
not shown). Strong signals corresponding to hGH and PreS/X tran-
cripts are visible in the cases of the HBV PreS/X (left) and the HBV
reS/X-D30 transcript (right). The strength of the PreS/X and PreS/X-
30 signals in comparison with their respective hGH signal intensities
s similar, indicating that the transcription rate of the deleted HBV 2.1-kb
ranscript is similar to its wildtype counterpart. Results are represen-
ative of three independent experiments.berrant splicing event in a transcript incorporating 635 tt of HBV sequence from the polymerase/surface anti-
en region located upstream from rabbit b-globin gene
equences. Splicing in this transcript was shown to in-
olve a splice donor site at HBV genome position 462
Cattaneo et al., 1984; Graef et al., 1994; Simonsen and
evinson, 1983; Wang et al., 1992) and a splice acceptor
ite of the rabbit b-globin intron 2 that is positioned 1048
t downstream. The genome region of HBV between nt
50 and 500 appears to be rich in splice consensus
equences. A splice acceptor site in the HBV genome
hat has been well characterized by several investigators
Rosmorduc et al., 1995; Su et al., 1989a; Suzuki et al.,
989; Wu et al., 1991) is positioned at HBV genome
osition 491, exactly 30 nt downstream from the splice
onor site at position 462. The multiple sequence align-
ent of 24 HBV genomes (see Fig. 2) in this region
evealed that a high degree of conservation among ge-
otypes exists with respect to these splice consensus
equences. This was puzzling considering the fact that
he majority of HBV transcripts are not spliced. It was
herefore hypothesized that the clustered splice consen-
us sequences in the genome region between nt 450
nd 500 played an important functional role in the life
ycle of HBV that was not at all or only indirectly asso-
iated with splicing. This possibility was investigated by
limination of the 30 nt positioned between the splice
onor site at position 462 and the splice acceptor site at
osition 491 in a HBV genome capable of replication in
ransfected cells. Deleted transcripts synthesized from
his construct, termed HBV-D30, would have been able to
erve as templates for the translation of all three known
embers of the surface antigen family as well as the
olymerase protein, each of them with a 10-aa in-frame
eletion.
The characterization of the D30 mutant in transiently
ransfected hepatoma and HEK 293 kidney cells in com-
arison with the WT revealed that the class of deleted
.1-kb transcripts appeared to be present in transfected
ells at very low levels. Consistent with the loss of 2.1-kb
ranscripts, no deleted M and s proteins were detectable
n transfected cells, and no (deleted) HBsAg could be
etected in cell culture supernatants. When CMV pro-
oter bearing constructs were transfected, the levels of
he 2.4-kb transcripts and 3.5-kb pregenomic transcripts
ere also substantially reduced, and consequently, the
mount of deleted L protein and core antigen were found
o be reduced to a similar extent (data not shown). When
ecircularized HBV monomers bearing the D30 deletion
ere transfected, the levels of the 2.4- and 3.5-kb tran-
cripts appeared to be similar to the WT. Importantly, the
.1-kb class of transcripts appeared to be absent, con-
irming the results obtained with the CMV promoter bear-
ng constructs. In summary, the deleted HBV genome
egion was found to be critically important for the main-
enance of high 2.1-kb transcript levels. Depending on
he type of construct transfected, the levels of all major
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252 ZU PUTLITZ, TONG, AND WANDSBV transcripts except the 0.9-kb class of (X protein-
ncoding) transcripts appeared to be differentially mod-
lated by the occurrence of the 30-nt deletion. Analysis
f transcription rates of the deleted 2.1-kb transcript in
omparison with the WT revealed no reductions, sug-
esting that the modulatory effect on 2.1-kb transcript
evels is mediated posttranscriptionally.
The precise mechanism of the 2.1-kb transcript desta-
ilization requires further investigation. In this regard,
iang and co-workers (personal communication) have
hown that point mutations at the potential splice donor
ite HBV position 462 and the splice acceptor site HBV
osition 491 were associated with decreased levels of
he 2.1-kb class of transcripts if a genetic element es-
ential for high-level expression of HBsAg (the HBV post-
ranscriptional regulatory element (PRE)) (Huang and Li-
ng, 1993; Huang and Yen, 1994) is also present on the
ame transcript. The presence of the PRE appears to be
mportant for the nucleocytoplasmic export of unspliced
BV transcripts. In view of these observations, a model
as proposed in analogy to the human immunodefi-
iency virus type 1 (HIV-1) protein Rev and its binding
equence on viral RNA, the Rev response element (RRE).
ev appears to increase the transport and utilization of
ll viral mRNA species that contain the RRE by inhibiting
he splicing process. For HBV, it was proposed that an
nteraction of RNA and/or RNA-binding proteins in the
egion of the PRE with components of the spliceosome
hat potentially associate with the putative splice donor
position 462) and/or acceptor sites (position 491) may
ead to inhibitory effects on splicing and enables high
opy numbers of unspliced (subgenomic) transcripts to
e translocated to the cytoplasm from the nucleus. This
ypothesis suggests that transcripts carrying the 30-nt
eletion studied here might be deficient for the associ-
tion with protein factors that play a role in efficient
ucleocytoplasmic transport.
It was observed that the pregenomic RNA containing
he deletion was encapsidated into core particles and
ubsequently reverse transcribed in a manner indistin-
uishable from the wildtype. Therefore, this study de-
ines a 10-aa stretch (aa 459 to 468) within the RT domain
aa 336–680) of HBV polymerase that appears to be
onessential for the function of reverse transcription of
regenomic RNA. The deletion in the RT domain of HBV
olymerase is positioned between the A domain (aa 423
o 439 in HBV adw2) and the B domain (aa 510 to 537)
hat are believed to be critical for RT function (Poch et al.,
989). Interestingly, a protein sequence alignment (not
llustrated) between HBV and DHBV polymerase re-
ealed that HBV polymerase amino acid sequences po-
itioned between the A and the B domains are absent in
HBV. This finding raises the possibility that the reverse
ranscriptase domain of HBV polymerase contains a pro-
ein “loop” between the A and the B domains that is
bsent in DHBV polymerase, and the data presented mere show that partial deletion of this protein loop does
ot disrupt viral DNA synthesis. It will be of interest to
nalyze polymerase deletion mutants in this region in
ore detail with respect to their function. Finally, it is also
oteworthy that the 10-aa deletion in the polymerase
rotein of the D30 mutant eliminated the C-terminal 5 aa
f a 9-aa-long, well-characterized HLA-A2.1-restricted
TL epitope (Pol455–463) located in the RT domain
Rehermann et al., 1995).
The deletion of 30 nt in the HBV genome between
ositions 462 and 491 leads to a polymerase mutant that
s capable of reverse transcription of viral RNA and to a
eleted L protein whose function appears to be unal-
ered when compared wit the wildtype (data not illustrat-
d). However, the D30 mutant lacks the capability to
ynthesize detectable amounts of M and s proteins.
hese properties are reminiscent of other types of pre-
iously described defective HBV genomes that have fre-
uently been found to exist in viral particles derived from
atients (Melegari et al., 1997). In such HBV variants, the
eficiency to synthesize M and s proteins is due to
eletions in the S promoter region of the 2.1-kb class of
ranscripts but may possibly be complemented in trans
y surface proteins produced from wildtype genomes.
hese observations raise the possibility that variant HBV
enomes incorporating the D30 deletion described here
ight occur in certain patients. Therefore, a sensitive
CR-based assay is under development to detect viral
enomes carrying the D30 deletion in patient sera, and
reliminary data obtained from a small group of patients
ith chronic hepatitis B suggest that variant HBV ge-
omes with the D30 deleetion indeed occur in some
ases.
In conclusion, a short region in the genome of HBV
as found to be critical for maintenance of high tran-
cript levels, especially in the case of the 2.1-kb sub-
enomic transcript. Polymerase translated from a mutant
evoid of this region is competent for viral DNA synthe-
is in vitro, but M and s proteins are strongly reduced
ue to loss of the corresponding transcripts. Further
tudy of this region of the HBV genome will yield insights
nto the regulation of HBV transcript levels in infected
ells. In addition, structure/function relationships in the
iral polymerase may be elucidated. The possible occur-
ence of the D30 mutant in patients may have implica-
ions for the study of virus–host interactions with respect
o the persistence of viral genomes within hepatocytes
nd the pathogenesis of this disease.
MATERIALS AND METHODS
NA constructs
A head-to-tail dimer of wildtype HBV, subtype adw
GenBank Accession No. X02763; (Blum et al., 1991)),
as digested with EcoRI and BglI to yield HBV DNA
onomers (3.2 kb), which were subsequently digested at
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253HBV TRANSCRIPT LEVEL DETERMINANTultiple sites with Sau3AI. The resulting subgenomic
ragments of HBV were inserted into the BamHI site of
he eukaryotic expression vector pC-GR N-795 (Rusconi
t al., 1990). Antisense and sense RNAs transcribed from
his plasmid (the orientation is given according to the
irection of transcription from the HBV genome) con-
ained 75 nt of CMV-IE promoter-derived sequence up-
tream of inserted HBV sequences and 379 nt of rabbit
-globin-like gene cluster-derived sequence (Margot et
l., 1989) downstream from the HBV sequences. The
eplication-competent construct pTC-HBV (von Weiz-
acker et al., 1996) (kindly provided by Stefan Wieland)
ontains a more-than-one-genome-length copy of the
BV genome subtype adw2 (3337 nt; from nt 1822 to nt
822 (3221 nt; G of EcoRI site is position 1) and continued
o nt 1937) under transcriptional control of the CMV-IE
romoter. In this construct, transcription of the HBV pre-
enomic (3.5 kb) RNA is driven by the heterologous
MV-IE promoter, whereas transcription of all sub-
enomic transcripts is controlled by their respective en-
ogenous promoters. A derivative of pTC-HBV, pTC-HBV-
30, containing a 30-nt in-frame deletion in the surface
ntigen/polymerase reading frame (nt 462 to 491 in HBV
dw2) was constructed in this study by overlap-exten-
ion PCR (Vallejo et al., 1995). The replication-competent
onstruct adw-R9 (Blum et al., 1991) contains a more-
han-one-genome-length copy of the HBV genome sub-
ype adw2 (3993 nt; from nt 1413 (AatII site) to nt 1413 and
ontinued to nit 2182) in a pGEM7 7Zf(1) vector. Similar
o the construction of pTC-HBV-D30, a derivative of
dw-R9 (adw-R9-D30) containing a 30-nt in-frame dele-
ion in the surface antigen/polymerase reading frame (nt
62 to 491 in HBV adw2) was constructed. adw-R9 and
dw-R9-D30 were used to generate linear HBV DNA
onomers by digestion with AatII, which, after recircu-
arization with T4 DNA ligase (New England Biolabs,
everly, MA), were transfected into cells.
For all PCR amplifications performed for cloning pur-
oses, the Expand High Fidelity PCR System (Boehringer
annheim, Indianapolis, IN) was used according to the
nstructions supplied by the manufacturer, typically using
reaction volume of 100 ml. Reaction conditions for
ot-start PCR were denaturation at 94°C for 1 min, 80°C
or 1 min (addition of enzyme), 94°C for 1 min; followed
y 25 cycles at 94°C for 1 min, 60°C for 30 s, 72°C for
0 s, and a final elongation step at 72°C for 10 min. Two
verlapping fragments of HBV that incorporated the 30-nt
eletion were amplified using 40 pmol each of primers
BV-XBA (20mer, 59-GCAGAGTCTAGACTCGTGGT-39)
nd D30-2 (33mer, 59-GTTGTTGTTGATCCTTGATAATC-
AGAAGAACC-39) in the first reaction and primers
30-1 (33mer, 59-CTGGATTATCAAGGATCAACAACAAC-
AGTACG-39) and HBV-SPE (21mer, 59-AATGGCACTAG-
AAACTGAGC-39) in the second reaction. In addition to 1
10
ol of 103 Expanded High Fidelity reaction buffer (final
oncentration of MgCl2 was 1.5 mM), the reaction mix- rure contained dNTPs at 200 nM each, 100 ng of tem-
late DNA pTC-HBV, and 0.5 ml (2.5 U) of Taq/Pwo DNA
olymerase mixture (Barnes, 1994). Both PCR products
ere gel-purified and used as templates in the final
verlap-extension PCR (conditions and volumes as de-
cribed above) containing 40 pmol each of primers HBV-
BA and HBV-SPE. The resulting PCR product was 408 nt
n length and contained the desired 30-nt deletion. It was
nserted into XbaI/SpeI-digested pTC-HBV to yield the
lone pTC-HBV-D30. The integrity and correct sequence
f several independent clones were confirmed by multi-
le restriction enzyme digestion analyses and dideoxy
equencing of the entire PCR-amplified region.
The construct pTC-HBV-FS645 (unpublished data) is
imilar to pTC-HBV but contains a 2-nt deletion at posi-
ion 645 in the adw2 genome that creates frameshifts in
he surface and polymerase proteins and renders this
BV clone encapsidation- and replication-incompetent.
n addition, this construct does not allow for any detect-
ble surface antigen expression, while the expression of
BV core antigen (HBcAg) is unchanged. This construct
as used for negative control purposes in certain exper-
ments (see Results). The construct HBV PreS/X (a kind
ift from Alan McLachlan) contains nt 2837–1989 of HBV
McLachlan et al., 1987). This construct allows for the
solated transcription of the 2.1-kb class of subgenomic
BV transcripts from which M and s surface antigens are
ranslated. A derivative of this construct, HBV PreS/X-
30, was generated by cassette-exchange cloning with
TC-HBV-D30 in order to introduce the 30-nt deletion
tudied here into the isolated context of the 2.1-kb class
f transcripts. For loading controls in some Northern
lotting experiments, a probe derived from the mouse
cidic ribosomal phosphoprotein PO (mARPP-PO) cDNA
Hurford et al., 1997; Krowczynska et al., 1989) (a kind gift
rom Robert K. Hurford) that cross-reacted with the hu-
an transcript was used. The expression construct for
GH, pTKGH (Selden et al., 1986), was used to correct for
ariations in transfection efficiencies (a kind gift from
mmett V. Schmidt).
T-PCR
For detection of the 2.1-kb class of subgenomic HBV
ranscripts, reverse transcription was performed using a
uperScript Preamplification System for First Strand
DNA Synthesis (Life Technologies, Gaithersburg, MD)
ith modifications. After extraction of total cellular RNA
ith the Ultraspec RNA isolation system (Biotecx Labo-
atories, Houston, TX), 1 to 1.5 mg of RNA was used in a
ne-tube DNase I/RT reaction as previously described
Huang et al., 1996). Initially, the DNase I reaction mixture
ontained 1
10
vol of 103 PCR buffer (200 mM Tris–HCl,
00 mM KCl; Life Technologies), 1 mM each of all four
NTPs, 0.5 mg of oligo(dT)12–18 primer, 10 U of RNasinibonuclease inhibitor (Promega, Madison, WI), 5 mM
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254 ZU PUTLITZ, TONG, AND WANDSgCl2 and 1 U of DNase I, RNase-free (Boehringer
annheim) in a final volume of 20 ml and was performed
or 30 min at 37°C, followed by an enzyme inactivation
tep of 5 min at 75°C. After addition of 200 U SuperScript
I RNase H2 reverse transcriptase, the RT reaction was
ncubated for 1 h at 42°C, followed by an enzyme inac-
ivation step of 15 min at 70°C. After addition of 2 U of
scherichia coli RNase H, the reaction was finally incu-
ated for 20 min at 37°C and stored at 240°C. For
egative control purposes, individual reactions were per-
ormed in parallel without addition of reverse transcrip-
ase. A 1
10
vol of each RT reaction (2 ml) was used in
ubsequent PCR detections of HBV subgenomic tran-
cripts, which were performed with upstream primer
9661 (27mer, 59-TGCCATTTGTTCAGTGGTTCGTAGG-
C-39) and downstream primer 2830- (26mer, 59-
CGGCAGATGAGAAGGCACAGACGG-39) (Kock et al.,
996) at 20 pmol each in a reaction volume of 100 ml. In
ddition to 1
10
vol of 103 PCR assay buffer (100 mM
ris–HCl (pH 8.3), 500 mM KCl, 15 mM MgCl2, 0.01%
elatin; Fisher Scientific), the reaction mixture contained
NTPs at 200 nM each and 1 ml (5 U) of Taq DNA
olymerase. The reaction conditions for PCR were de-
aturation at 94°C for 3 min, followed by 25 cycles at
4°C for 1 min, 64°C for 1 min, 72°C for 1 min and a final
longation step at 72°C for 10 min. PCR products were
ractionated on 2% agarose gels and visualized by
thidium bromide staining and Southern blotting.
ells and transfections
The human HCC cell line HuH-7 (Nakabayashi et al.,
982) was grown in modified Eagle’s minimal essential
edium (MEM; Cellgro Mediatech, Washington, DC),
upplemented with 10% fetal calf serum (FCS), 1% non-
ssential amino acid solution (Life Technologies), and
% penicillin/streptomycin stock solution (Cellgro Medi-
tech). This cell line supports a complete viral replication
ycle and produces virions after transient transfection
ith HBV-containing plasmids. The HEK 293 human em-
ryo kidney cell line (Graham et al., 1977) was grown in
ulbecco’s modified Eagle’s medium (DMEM; Cellgro
ediatech), supplemented with 10% FCS, 1% nonessen-
ial amino acid solution (Life Technologies), and 1% pen-
cillin/streptomycin stock solution. Transfections were
erformed using a modified calcium phosphate precipi-
ation protocol (Chen et al., 1996) routinely using 20 mg of
NA plus 1 mg of reporter plasmid pTKGH (Selden et al.,
986) per 100-mm plate seeded with 7 3 106 cells.
NA and RNA analyses
For the preparation of core-associated HBV DNA,
ransfected cells were lysed in NP-40 lysis buffer (50 mM
ris–HCl (pH 8.0)–1 mM EDTA–1% Nonidet-P40). The
ysate was centrifuged at 10,000 g for 5 min at room
emperature. After the addition of CaCl2 and MgCl2 to a Pinal concentration of 10 mM each, the supernatant was
ncubated with 20 U/ml of DNase I (Boehringer Mann-
eim) and micrococcal nuclease (final concentration 150
/ml; Pharmacia Biotech, Piscataway, NJ) for 2 h at 37°C.
ext, EDTA (20 mmol/L), 10% sodium dodecyl sulfate
1%), and proteinase K (1 mg/ml; Promega, Madison, WI)
ere added, followed by incubation for 12 to 16 h at
7°C. Finally, the sample was extracted once with 1 vol
henol/chloroform. The DNA was precipitated with 1 vol
f isopropanol. The DNA pellet was resuspended in 20
l of agarose gel loading buffer. Total cellular RNA was
xtracted with the Ultraspec RNA isolation system (Bio-
ecx Laboratories). Polyethyleneglycol precipitations of
BV nucleocapsids from the cell lysate were performed
s described (Tong et al., 1992). DNA was fractionated by
.2% agarose gel electrophoresis in Tris–acetate buffer
Ausubel et al., 1987). RNA was analyzed by formalde-
yde–1.2% agarose gel electrophoresis as described
Blum et al., 1991). Nucleic acids were transferred to
ybond-N1 nylon membranes (Amersham Life Science,
rlington Heights, IL). After UV-crosslinking of nucleic
cids (1.2 3 105 mJ/cm2), membranes were prehybridized
or 4 h at 42°C in 50% (vol/vol) formamide–53 SSPE (13
SPE is 0.15 M NaCl, 0.01 M sodium dihydrogen phos-
hate, 1 mM EDTA)–2.53 Denhardt’s solution (13 Den-
ardt’s solution is 0.02% polyvinylpyrrolidone, 0.02% Fi-
oll, 0.02% bovine serum albumin)–0.1% SDS–200 mg of
enatured calf thymus DNA per milliliter. Hybridization
ith recombinant full-length HBV DNA labeled to high
pecific activity (2 3 108 to 4 3 108 cpm/mg) was per-
ormed in the same buffer for 16 h at 42°C. After hybrid-
zation, membranes were washed once in 53 SSC–0.1%
DS for 5 min at 42°C and once in 13 SSC–0.1% SDS for
0 min at 65°C and exposed.
uclear run-on assay
Transcription rates were determined using a nuclear
un-on assay according to a published protocol (Ausubel
t al., 1987). Briefly, HuH-7 cells were transfected with
onstructs HBV PreS/X or HBV PreS/X-D30. The expres-
ion construct for human growth hromone, pTKGH, was
otransfected in each case. Nuclei were prepared by
ysis with NP-40 lysis buffer after 24 h and stored in
lycerol buffer (50 mM Tris–HCl, pH 8.3, 40% glycerol, 5
M MgCl2, 0.1 M EDTA) at 280°C. Nuclei from one
ransfected 100-mm cell culture plate (100 ml) were then
ncubated with 100 ml reaction buffer (10 mM Tris–HCl,
H 8.0, 5 mM MgCl2, 300 mM KCl, 5 mM DTT) containing
.5 mM each of ATP, CTP, and GTP, 100 mCi of [a-32P]UTP
10 mCi/ml), and 1 U/ml RNasin (Promega). After incuba-
ion at 30°C for 60 min, the reaction was extracted with
henol/chloroform, precipitated, dissolved in 50 ml TE,
nd finally hybridized to nylon membranes onto which
inearized, single-stranded plasmids (10 mg each) HBV
reS/X, pTKGH, mARPP-PO, and pUC13 had been spot-
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255HBV TRANSCRIPT LEVEL DETERMINANTed using a dot blot apparatus. Signals were quantified
sing a phosphoimaging system.
nzymatic and immunological assays
For the determination of transfection efficiencies, a
ommercially available assay for secreted human growth
ormone (Tandem-R HGH; Hybritech, San Diego, CA)
as used. Hepatitis B virus surface antigen (HBsAg),
ore antigen (HBcAg), and e antigen (HBeAg) levels in
ell culture supernatants were determined by commer-
ially available immunoassays (Abbott Laboratories,
orth Chicago, IL).
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